Literature DB >> 23334123

Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET.

Elena Prieto1, Inés Domínguez-Prado, María José García-Velloso, Iván Peñuelas, José Ángel Richter, Josep Maria Martí-Climent.   

Abstract

BACKGROUND: Accuracy in the quantification of the SUV is a critical point in PET because proper quantification of tumor uptake is essential for therapy monitoring and prognosis evaluation. Recent advances such as time-of-flight (TOF) and point-spread-function (PSF) reconstructions have dramatically improved detectability. However, first experiences with these techniques have shown a consistent tendency to measure markedly high SUV values, bewildering nuclear medicine physicians and referring clinicians.
PURPOSE: We investigated different reconstruction and quantification procedures to determine the optimum protocol for an accurate SUV quantification in last generation PET scanners.
METHODS: Both phantom and patient images were evaluated. A complete set of experiments was performed using a body phantom containing 6 spheres with different background levels and contrasts. Whole-body FDG PET/CT of 20 patients with breast and lung cancer was evaluated. One hundred five foci were identified by 2 experienced nuclear medicine physicians.Each acquisition was reconstructed both with classical and advanced (TOF, PSF) reconstruction techniques. Each sphere and each in vivo lesion was quantified with different parameters as follows: SUV(max), SUV(mean), and SUV(50) (mean within a 50% isocontour).
RESULTS: This study has confirmed that quantification with SUV(max) produces important overestimation of metabolism in new generation PET scanners. This is a relevant result because, currently, SUV(max) is the standard parameter for quantification. SUV(50) has been shown as the best alternative, especially when applied to images reconstructed with PSF + TOF.
CONCLUSIONS: SUV(50) provides accurate quantification and should replace SUV(max) in PET tomographs incorporating advanced reconstruction techniques. PSF + TOF reconstruction is the optimum for both detection and accurate quantification.

Entities:  

Mesh:

Year:  2013        PMID: 23334123     DOI: 10.1097/RLU.0b013e318279b9df

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  20 in total

1.  Determination of accuracy and precision of lesion uptake measurements in human subjects with time-of-flight PET.

Authors:  Margaret E Daube-Witherspoon; Suleman Surti; Amy E Perkins; Joel S Karp
Journal:  J Nucl Med       Date:  2014-03-06       Impact factor: 10.057

2.  MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.

Authors:  Maria J Garcia-Velloso; Maria J Ribelles; Macarena Rodriguez; Alejandro Fernandez-Montero; Lidia Sancho; Elena Prieto; Marta Santisteban; Natalia Rodriguez-Spiteri; Miguel A Idoate; Fernando Martinez-Regueira; Arlette Elizalde; Luis J Pina
Journal:  Eur Radiol       Date:  2016-12-21       Impact factor: 5.315

3.  The impact of iterative reconstruction protocol, signal-to-background ratio and background activity on measurement of PET spatial resolution.

Authors:  Sahar Rezaei; Pardis Ghafarian; Mehrdad Bakhshayesh-Karam; Carlos F Uribe; Arman Rahmim; Saeed Sarkar; Mohammad Reza Ay
Journal:  Jpn J Radiol       Date:  2020-01-01       Impact factor: 2.374

4.  Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT.

Authors:  Johannes Schwenck; Hansjoerg Rempp; Gerald Reischl; Stephan Kruck; Arnulf Stenzl; Konstantin Nikolaou; Christina Pfannenberg; Christian la Fougère
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-24       Impact factor: 9.236

5.  Quantitative differences in [(18)F] NaF PET/CT: TOF versus non-TOF measurements.

Authors:  Jorge D Oldan; Timothy G Turkington; Kingshuk Choudhury; Bennett B Chin
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 6.  Pitfalls on PET/CT Due to Artifacts and Instrumentation.

Authors:  Yu-Jung Tsai; Chi Liu
Journal:  Semin Nucl Med       Date:  2021-07-07       Impact factor: 4.446

7.  The clinical effectiveness of reconstructing 18F-sodium fluoride PET/CT bone using Bayesian penalized likelihood algorithm for evaluation of metastatic bone disease in obese patients.

Authors:  Sharjeel Usmani; Najeeb Ahmed; Gopinath Gnanasegaran; Rashid Rasheed; Fahad Marafi; Mashari Alnaaimi; Mohammad Omar; Ahmed Musbah; Fareeda Al Kandari; Stijn De Schepper; Tim Van den Wyngaert
Journal:  Br J Radiol       Date:  2021-02-11       Impact factor: 3.039

8.  Impact of time-of-flight on qualitative and quantitative analyses of myocardial perfusion PET studies using (13)N-ammonia.

Authors:  Takeshi Tomiyama; Keiichi Ishihara; Masaya Suda; Koji Kanaya; Minoru Sakurai; Naoto Takahashi; Hitoshi Takano; Koichi Nitta; Kenta Hakozaki; Shin-ichiro Kumita
Journal:  J Nucl Cardiol       Date:  2014-12-03       Impact factor: 5.952

9.  New PET technologies - embracing progress and pushing the limits.

Authors:  Nicolas Aide; Charline Lasnon; Adam Kesner; Craig S Levin; Irene Buvat; Andrei Iagaru; Ken Hermann; Ramsey D Badawi; Simon R Cherry; Kevin M Bradley; Daniel R McGowan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-03       Impact factor: 9.236

10.  Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies.

Authors:  Ian S Armstrong; Matthew D Kelly; Heather A Williams; Julian C Matthews
Journal:  EJNMMI Phys       Date:  2014-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.